ABBV

AbbVie
ABBV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$329.14B
EV
$391.64B
Shares Outstanding
1.77B
Beta
0.54

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$210.70
P/E 2025E
15.24x
P/Revenue 2025E
5.48x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About AbbVie Inc.

gainify
ABBV

AbbVie Inc.

ABBV

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disea...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Michael, Robert

Employees

55,000

IPO Date

2013-01-02

Headquarters

1 North Waukegan Road, North Chicago, Illinois, 60064-6400, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved